Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

Vanderlocht J, van Beers JJBC, Limburg PC, Damoiseaux J, Roozendaal C.

Methods Mol Biol. 2019;1901:153-176. doi: 10.1007/978-1-4939-8949-2_12.

PMID:
30539575
2.

Identification of Lifelines participants at high risk for development of rheumatoid arthritis.

Arends S, Trouw LA, Toes REM, van Zanten A, Roozendaal C, Limburg PC, Bootsma H, Brouwer E.

Ann Rheum Dis. 2017 Nov;76(11):e43. doi: 10.1136/annrheumdis-2017-211256. Epub 2017 Mar 8. No abstract available.

PMID:
28274913
3.

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Schaper F, de Leeuw K, Horst G, Maas F, Bootsma H, Heeringa P, Limburg PC, Westra J.

Clin Exp Immunol. 2017 Jun;188(3):412-419. doi: 10.1111/cei.12951. Epub 2017 Mar 27.

4.

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.

van Zanten A, Arends S, Roozendaal C, Limburg PC, Maas F, Trouw LA, Toes REM, Huizinga TWJ, Bootsma H, Brouwer E.

Ann Rheum Dis. 2017 Jul;76(7):1184-1190. doi: 10.1136/annrheumdis-2016-209991. Epub 2017 Jan 2.

5.

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.

Schaper F, de Leeuw K, Horst G, Bootsma H, Limburg PC, Heeringa P, Bijl M, Westra J.

Rheumatology (Oxford). 2016 Dec;55(12):2260-2270. Epub 2016 Sep 15.

PMID:
27632996
6.

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice.

Schaper F, van Timmeren MM, Petersen A, Horst G, Bijl M, Limburg PC, Westra J, Heeringa P.

Mol Med. 2016 Sep;22:12-21. doi: 10.2119/molmed.2015.00176. Epub 2016 Jan 13.

7.

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

de Souza AW, Abdulahad WH, Sosicka P, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG.

Clin Exp Immunol. 2014 Nov;178(2):270-8. doi: 10.1111/cei.12422.

8.

Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.

Souza AW, de Leeuw K, van Timmeren MM, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG.

PLoS One. 2014 Apr 28;9(4):e96067. doi: 10.1371/journal.pone.0096067. eCollection 2014.

9.

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

de Souza A, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CG.

Arthritis Res Ther. 2013;15(5):R104.

10.

Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).

Abdulahad WH, Lepse N, Stegeman CA, Huitema MG, Doornbos-van der Meer B, Tadema H, Rutgers A, Limburg PC, Kallenberg CG, Heeringa P.

Arthritis Res Ther. 2013;15(3):R70.

11.

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

Abdulahad DA, Westra J, Reefman E, Zuidersma E, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.

Lupus. 2013 May;22(6):597-606. doi: 10.1177/0961203313483377. Epub 2013 Apr 2.

PMID:
23549344
12.

Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Dolff S, Abdulahad WH, Arends S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2013 Feb 27;15(1):R36. doi: 10.1186/ar4189.

13.

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.

Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2012 Aug 14;14(4):R184. doi: 10.1186/ar4015.

14.

HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.

de Souza AW, Westra J, Limburg PC, Bijl M, Kallenberg CG.

Autoimmun Rev. 2012 Oct;11(12):909-17. doi: 10.1016/j.autrev.2012.03.007. Epub 2012 Apr 1. Review.

PMID:
22495229
15.

Fluorescent cell barcoding as a tool to assess the age-related development of intracellular cytokine production in small amounts of blood from infants.

Stam J, Abdulahad W, Huitema MG, Roozendaal C, Limburg PC, van Stuijvenberg M, Schölvinck EH.

PLoS One. 2011;6(10):e25690. doi: 10.1371/journal.pone.0025690. Epub 2011 Oct 17.

16.

Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.

Dolff S, Abdulahad WH, Westra J, Doornbos-van der Meer B, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2011;13(5):R157. doi: 10.1186/ar3474. Epub 2011 Sep 29.

17.

Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.

Dolff S, Bijl M, Huitema MG, Limburg PC, Kallenberg CG, Abdulahad WH.

Clin Immunol. 2011 Nov;141(2):197-204. doi: 10.1016/j.clim.2011.08.005. Epub 2011 Aug 16.

PMID:
21920821
18.

Measurable regression of systemic light chain (AL) amyloid in fat tissue after a response of amyloidogenic free light chain in serum.

van Gameren II, Bijzet J, Bos R, Limburg PC, Vellenga E, Hazenberg BP.

Amyloid. 2011 Jun;18 Suppl 1:94-5. doi: 10.3109/13506129.2011.574354034. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:95.

PMID:
21838446
19.

Diagnostic performance of transthyretin measurement in fat tissue of patients with ATTR amyloidosis.

Hazenberg BP, van Schijndel B, Bijzet J, Limburg PC, Bos R, Haagsma EB.

Amyloid. 2011 Jun;18 Suppl 1:79. doi: 10.3109/13506129.2011.574354028. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:79.

PMID:
21838440
20.

Diagnostic performance of measuring free light chains in fat tissue of patients with AL amyloidosis.

Bijzet J, van Gameren II, Limburg PC, Bos R, Vellenga E, Hazenberg BP.

Amyloid. 2011 Jun;18 Suppl 1:71-2. doi: 10.3109/13506129.2011.574354025. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:72.

PMID:
21838437
21.

Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis.

Arends S, van der Veer E, Groen H, Houtman PM, Jansen TL, Leijsma MK, Bijzet J, Limburg PC, Kallenberg CG, Spoorenberg A, Brouwer E.

J Rheumatol. 2011 Aug;38(8):1644-50. doi: 10.3899/jrheum.101128. Epub 2011 Jun 1.

PMID:
21632677
22.

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2011 May 6;13(3):R71. doi: 10.1186/ar3332.

23.

The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.

Arends S, Lebbink HR, Spoorenberg A, Bungener LB, Roozendaal C, van der Veer E, Houtman PM, Griep EN, Limburg PC, Kallenberg CG, Wolbink GJ, Brouwer E.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5):661-8. Epub 2010 Oct 22.

PMID:
20822711
24.

Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder.

Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1390-5. doi: 10.1016/j.pnpbp.2010.06.028. Epub 2010 Jul 3.

PMID:
20599460
25.

HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.

Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M.

Autoimmun Rev. 2010 Aug;9(10):661-5. doi: 10.1016/j.autrev.2010.05.015. Epub 2010 May 21. Review.

PMID:
20546955
26.

Urinary T cells in active lupus nephritis show an effector memory phenotype.

Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2010 Nov;69(11):2034-41. doi: 10.1136/ard.2009.124636. Epub 2010 May 14.

PMID:
20472588
27.

Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis.

Brouwer E, Gouw AS, Posthumus MD, van Leeuwen MA, Boerboom AL, Bijzet J, Bos R, Limburg PC, Kallenberg CG, Westra J.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):945-51.

PMID:
20149310
28.

AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.

Nienhuis HL, Westra J, Smit AJ, Limburg PC, Kallenberg CG, Bijl M.

Autoimmunity. 2009 May;42(4):302-4. Review.

PMID:
19811283
29.

Role for CaMKII inhibition in rheumatoid arthritis: effects on HIF-1-induced VEGF production by rheumatoid synovial fibroblasts.

Westra J, Brouwer E, Bouwman E, Doornbos-van der Meer B, Posthumus MD, van Leeuwen MA, Limburg PC, Ueda Y, Kallenberg CG.

Ann N Y Acad Sci. 2009 Sep;1173:706-11. doi: 10.1111/j.1749-6632.2009.04736.x.

PMID:
19758219
30.

Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.

Abdulahad WH, Kallenberg CG, Limburg PC, Stegeman CA.

Arthritis Rheum. 2009 Sep;60(9):2830-8. doi: 10.1002/art.24747.

31.
32.

Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.

Hu N, Westra J, Huitema MG, Stegeman CA, Limburg PC, Kallenberg CG.

Nephrology (Carlton). 2009 Feb;14(1):11-5. doi: 10.1111/j.1440-1797.2008.01068.x. Epub 2008 Feb 2.

PMID:
19207860
33.

Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.

Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG.

Arthritis Rheum. 2008 Jul;58(7):2196-205. doi: 10.1002/art.23557.

34.

Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.

Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Rheum. 2007 Oct;56(10):3399-411.

35.

Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.

Schipper HS, Rutgers B, Huitema MG, Etuaful SN, Westenbrink BD, Limburg PC, Timens W, van der Werf TS.

Clin Exp Immunol. 2007 Dec;150(3):451-9. Epub 2007 Sep 27.

36.

Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts.

Westra J, Brouwer E, Bos R, Posthumus MD, Doornbos-van der Meer B, Kallenberg CG, Limburg PC.

Ann N Y Acad Sci. 2007 Jun;1108:340-8.

PMID:
17893997
37.

CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis.

Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG.

Ann N Y Acad Sci. 2007 Jun;1107:22-31.

PMID:
17804529
38.

Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes.

van der Geld YM, Hellmark T, Selga D, Heeringa P, Huitema MG, Limburg PC, Kallenberg CG.

Ann Rheum Dis. 2007 Dec;66(12):1679-82. Epub 2007 Jul 20.

39.

Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.

Hazenberg BP, Bijzet J, Limburg PC, Skinner M, Hawkins PN, Butrimiene I, Livneh A, Lesnyak O, Nasonov EL, Filipowicz-Sosnowska A, Gül A, Merlini G, Wiland P, Ozdogan H, Gorevic PD, Maïz HB, Benson MD, Direskeneli H, Kaarela K, Garceau D, Hauck W, Van Rijswijk MH.

Amyloid. 2007 Jun;14(2):133-40. Erratum in: Amyloid. 2007 Dec;14(4):325.

PMID:
17577686
40.

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG.

Arthritis Rheum. 2007 Jun;56(6):2080-91.

41.

Inflammatory clearance of apoptotic cells after UVB challenge.

Bijl M, Reefman E, Limburg PC, Kallenberg CG.

Autoimmunity. 2007 Jun;40(4):244-8. Review.

PMID:
17516204
42.

Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.

Reefman E, Kuiper H, Limburg PC, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2008 Jan;67(1):11-18.

PMID:
17502354
43.

Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.

van Rossum AP, Huitema MG, Stegeman CA, Bijl M, de Leeuw K, Van Leeuwen MA, Limburg PC, Kallenberg CG.

Ann Rheum Dis. 2007 Oct;66(10):1350-5. Epub 2007 Apr 19. Erratum in: Ann Rheum Dis. 2007 Dec;66(12):1688. Ann Rheum Dis. 2007 Nov;66(11):1548.

44.

Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?

Reefman E, de Jong MC, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2006;8(6):R156.

45.
46.

p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis.

Westra J, Limburg PC.

Mini Rev Med Chem. 2006 Aug;6(8):867-74. Review.

PMID:
16918493
47.

Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?

Kallenberg CG, Stegeman CA, Bootsma H, Bijl M, Limburg PC.

Lupus. 2006;15(7):397-402. Review.

PMID:
16898172
48.

Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis.

van Rossum AP, Pas HH, Fazzini F, Huitema MG, Limburg PC, Jonkman MF, Kallenberg CG.

Arthritis Rheum. 2006 Mar;54(3):986-91.

49.

Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.

Reefman E, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG, Bijl M.

Rheumatology (Oxford). 2006 May;45(5):538-44. Epub 2005 Dec 13.

PMID:
16352635
50.

Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosus.

Limburg PC, Bijl M.

Ann Rheum Dis. 2005 Dec;64(12):1669-70. No abstract available.

Supplemental Content

Loading ...
Support Center